Stereotactic body radiotherapy versus surgery for medically operable stage i non-small-cell lung cancer: A Markov model-based decision analysis

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages 964-973

  Louie, Alexander V ^a   Rodrigues, George ^a   Hannouf, Malek ^a   Zaric, Gregory S ^a,b   Palma, David A ^a   Cao, Jeffrey Q ^a,b   Yaremko, Brian P ^a   Malthaner, Richard ^a   Mocanu, Joseph D ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

decision analysis; lobectomy; Markov model; quality of life; Stereotactic body radiotherapy

Indexed keywords

CAUSES OF DEATH; LIFE EXPECTANCIES; LOBECTOMY; LUNG CANCER; MARKOV MODEL; NON SMALL CELL LUNG CANCER; OUTCOME PREDICTION; OVERALL SURVIVAL; PREDICTION TOOLS; PROSPECTIVE STUDY; QUALITY OF LIFE; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC BODY RADIOTHERAPY; SURGICAL RESECTION; TIME FRAME;

BIOLOGICAL ORGANS; DECISION MAKING; DISEASES; MARKOV PROCESSES; RADIOTHERAPY;

SURGERY;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CASE REPORT; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HIDDEN MARKOV MODEL; HUMAN; LIFE EXPECTANCY; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING; STEREOTACTIC BODY RADIATION THERAPY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CAUSE OF DEATH; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LIFE EXPECTANCY; LUNG NEOPLASMS; MALE; MARKOV CHAINS; NEOPLASM STAGING; PNEUMONECTOMY; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RADIOSURGERY; REPRODUCIBILITY OF RESULTS; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SMOKING;

EID: 80255134570     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.040     Document Type: Article

References (53)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. M.Y. Chang, and D.J. Sugarbaker Surgery for early stage non-small cell lung cancer Semin Surg Oncol 21 2003 74 84 (Pubitemid 37237416)
3. N. Martini, M.S. Bains, and M.E. Burt Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
4. R. Rami-Porta, D. Ball, and J. Crowley The IASLC Lung Cancer Staging Project: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 593 602 (Pubitemid 47171780)
5. D.J. Raz, J.A. Zell, and S.H. Ou Natural history of stage I non-small cell lung cancer: Implications for early detection Chest 132 2007 193 199 (Pubitemid 47068221)
6. N.P. Rowell, and C.J. Williams Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): A systematic review Thorax 56 2001 628 638 (Pubitemid 32706145)
7. D.E. Dosoretz, D. Galmarini, and J.H. Rubenstein Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication Int J Radiat Oncol Biol Phys 27 1993 507 516 (Pubitemid 23331115)
8. X. Qiao, O. Tullgren, and I. Lax The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11 (Pubitemid 36765477)
9. N.P. Rowell, and C.J. Williams Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable) Cochrane Database Syst Rev 2001 CD002935
10. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
11. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
12. F.J. Lagerwaard, C.J. Haasbeek, and E.F. Smit Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
13. G.M. Videtic, K. Stephans, and C. Reddy Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: Excellent local control Int J Radiat Oncol Biol Phys 77 2009 344 349
14. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
15. C.M. Mery, A.N. Pappas, and R. Bueno Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database Chest 128 2005 237 245 (Pubitemid 40994479)
16. R. Manser, G. Wright, and D. Hart Surgery for early stage non-small cell lung cancer Cochrane Database Syst Rev 2005 CD004699
17. C.W. Hurkmans, J.P. Cuijpers, and F.J. Lagerwaard Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: Report from the Quality Assurance Working Party of the randomised phase III ROSEL study Radiat Oncol 4 2009 1
18. R.M. Shavelle, D.R. Paculdo, and D.J. Strauss Smoking habit and mortality: A meta-analysis J Insur Med 40 2008 170 178
19. V. Cangemi, P. Volpino, and N. D'Andrea Results of surgical treatment of stage IIIA non-small cell lung cancer Eur J Cardiothorac Surg 9 1995 352 359
20. D.H. Harpole Jr., J.E. Herndon 2nd, and W.G. Young Jr. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence Cancer 76 1995 787 796
21. L. Trodella, P. Granone, and S. Valente Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: Definitive results of a phase III randomized trial Radiother Oncol 62 2002 11 19 (Pubitemid 34121945)
22. M.S. Allen, G.E. Darling, and T.T. Pechet Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 trial Ann Thorac Surg 81 2006 1013 1019 discussion 1019-1020
23. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy vs. limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622 discussion 622-613
24. S. Watanabe, H. Asamura, and K. Suzuki Recent results of postoperative mortality for surgical resections in lung cancer Ann Thorac Surg 78 2004 999 1002 discussion 1002-1003 (Pubitemid 39164820)
25. Y. Nagata, M. Hiraoka, and T. Mizowaki Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group Int J Radiat Oncol Biol Phys 75 2009 343 347
26. X.W. Cai, L.Y. Xu, and L. Wang Comparative survival in patients with postresection recurrent vs. newly diagnosed non-small-cell lung cancer treated with radiotherapy Int J Radiat Oncol Biol Phys 76 2009 1100 1105
27. J.P. Pignon, H. Tribodet, and G.V. Scagliotti Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
28. K. Furuse, M. Fukuoka, and M. Kawahara Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699 (Pubitemid 29415225)
29. Surveillance, Epidemiology, End-Results: SEER Cancer Statistics Review 1973-2006. National Cancer Institute Section 17- Lung, 1973-2006; 2006.
30. S. Tyldesley, C. Boyd, and K. Schulze Estimating the need for radiotherapy for lung cancer: An evidence-based, epidemiologic approach Int J Radiat Oncol Biol Phys 49 2001 973 985 (Pubitemid 32184604)
31. J.Y. Chang, P.A. Balter, and L. Dong Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 967 971
32. R.O. Dillman, J. Herndon, and S.L. Seagren Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215 (Pubitemid 26302034)
33. National Center for Health Statistics. Available at: http://www.cdc.gov/ nchs/data/nvsr/nvsr54/nvsr54-14.pdf. Last accessed August 12, 2010.
34. F.J. Papatheofanis Utility evaluations for Markov states of lung cancer for PET-based disease management Q J Nucl Med 44 2000 186 190 (Pubitemid 30623523)
35. W.B. Van Den Hout, G.W. Kramer, and E.M. Noordijk Cost-utility analysis of short- vs. long-course palliative radiotherapy in patients with non-small-cell lung cancer J Natl Cancer Inst 98 2006 1786 1794 (Pubitemid 46017930)
36. B.J. McNeil, R. Weichselbaum, and S.G. Pauker Fallacy of the five-year survival in lung cancer N Engl J Med 299 1978 1397 1401 (Pubitemid 9092483)
37. N.C. Van Der Voort Van Zyp, J.B. Prevost, and B. Van Der Holt Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 77 2009 31 37
38. M.T. Milano, L.S. Constine, and P. Okunieff Normal tissue toxicity after small field hypofractionated stereotactic body radiation Radiat Oncol 3 2008 36
39. T. Win, L. Sharples, and F.C. Wells Effect of lung cancer surgery on quality of life Thorax 60 2005 234 238 (Pubitemid 40380284)
40. R.E. Dales, R. Belanger, and F.M. Shamji Quality-of-life following thoracotomy for lung cancer J Clin Epidemiol 47 1994 1443 1449
41. P.M. Kenny, M.T. King, and R.C. Viney Quality of life and survival in the 2 years after surgery for non small-cell lung cancer J Clin Oncol 26 2008 233 241
42. M.K. Ali, M.S. Ewer, and M.R. Atallah Regional and overall pulmonary function changes in lung cancer. Correlations with tumor stage, extent of pulmonary resection, and patient survival J Thorac Cardiovasc Surg 86 1983 1 8 (Pubitemid 13071674)
43. M.L. Rogers, and J.P. Duffy Surgical aspects of chronic post-thoracotomy pain Eur J Cardiothorac Surg 18 2000 711 716
44. Y. Gotoda, N. Kambara, and T. Sakai The morbidity, time course and predictive factors for persistent post-thoracotomy pain Eur J Pain 5 2001 89 96 (Pubitemid 32661931)
45. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839 (Pubitemid 46630909)
46. T.J. Kirby, M.J. Mack, and R.J. Landreneau Lobectomy - video-assisted thoracic surgery vs. muscle-sparing thoracotomy. A randomized trial J Thorac Cardiovasc Surg 109 1995 997 1001 discussion 1001-1002
47. K. Sugi, Y. Kaneda, and K. Esato Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer World J Surg 24 2000 27 30 discussion 30-21
48. T.D. Yan, D. Black, and P.G. Bannon Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer J Clin Oncol 27 2009 2553 2562
49. I.S. Grills, V.S. Mangona, and R. Welsh Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 925 928
50. R.D. Timmerman Surgery vs. stereotactic body radiation therapy for early-stage lung cancer: Who's down for the count? J Clin Oncol 28 2010 907 909
51. C.J. Haasbeek, F.J. Lagerwaard, and M.E. Antonisse Stage I nonsmall cell lung cancer in patients aged > or = 75 years: Outcomes after stereotactic radiotherapy Cancer 116 2010 406 414
52. K.L. Stephans, T. Djemil, and C.A. Reddy Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients J Thorac Oncol 4 2009 838 844
53. M. Henderson, R. McGarry, and C. Yiannoutsos Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 404 409